BrigittaCBrottMD

Cardiology • Birmingham, AL

Interventional Cardiology

Professor of Medicine and Biomedical Engineering

Join to view full profile

Dr. Brott is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Brott's full profile

Already have an account?

Office
1717 6th Ave S
Birmingham, AL 35233
Phone+1 800-822-8816

Summary

Professor of Medicine and Biomedical Engineering;
Co-Founder & Chief Medical Officer, Endomimetics, LLC

Education & Training

Duke University HospitalFellowship, Cardiovascular Disease, 1991 - 1995
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1988 - 1991
Loyola University Chicago Stritch School of MedicineClass of 1988
Massachusetts Institute of TechnologyBS, 1980 - 1984

Certifications & Licensure

AL State Medical License 2000 - 2024
IL State Medical License 2000 - 2002
TN State Medical License 1995 - 2002
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Fellow (FACC) American College of Cardiology

Publications & Presentations

PubMed

206 citations
Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.
Larisa H. Cavallari, Craig R. Lee, Amber L. Beitelshees, Rhonda M. Cooper-DeHoff, Julio D. Duarte
JACC. Cardiovascular Interventions. 2018-01-22
14 citations
Oral antiplatelet therapy in diabetes mellitus and the role of prasugrel: an overview.
William B. Hillegass, Brigitta C. Brott, James C Dobbs, Silvio E. Papapietro, Vijay K. Misra
Vascular Health and Risk Management. 2011-07-18
109 citations
A Nitric Oxide Releasing, Self Assembled Peptide Amphiphile Matrix that Mimics Native Endothelium for Coating Implantable Cardiovascular Devices
Meenakshi Kushwaha, Joel M. Anderson, Charles A. Bosworth, Adinarayana Andukuri, William P. Minor
Biomaterials. 2010-03-01

Authored Content

Drug-Eluting Balloon Therapy for in-Stent Restenosis of Drug-Eluting Stents Choose and Prepare the Appropriate LesionMay 2018

Press Mentions

A Novel Therapy Ameliorates Obesity and Type 2 Diabetes in Mice Fed a High-Fat DietApril 29th, 2022
Massive Pulmonary Embolism in a COVID-19 Patient: A Case ReportJuly 21st, 2020
Drug-Eluting Balloons Come up Short for in-Stent RestenosisMay 21st, 2018
Join now to see all

Professional Memberships

American College of Cardiology - ACC
Fellow